News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
BioPharm Executive - Money Talk
New Cambridge-Based Biotech VC Firm Remiges BioPharma Emerges, Eyes $150 Million Fund 7/25/2014
Sofinnova Ventures Raises $500 Million Biotech Venture Fund 7/23/2014
StemCells Inc. (STEM) Announces Closing Of $20 Million Offering 7/21/2014
VC Firm Versant Ventures Closes In On $300 Million Fund For Medtech And Biotech 7/9/2014
National Institutes of Health (NIH) Has A New $248 Million Focus: Electroceuticals 7/7/2014
Cambridge Startup Navitor Pharmaceuticals Debuts With $23.5 Million Series A In Pocket 6/20/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Terminates Development Of Top Prostate Cancer Prospect Orteronel 6/20/2014
Fremont Biotech Ardelyx Inc. (ARDX) Prices IPO At $14 Per Share 6/19/2014
South San Francisco's True North Therapeutics Reels In $22 Million Series A Financing 6/18/2014
Berkeley's Aduro Biotech Reels In $55 Million Series C Financing 6/13/2014
Gene Therapy Biotech Vascular Biogenics Ltd. Files For A $75 Million IPO 6/9/2014
San Francisco Biotech Startup Nurix Taps $25.1 Million Financing 5/27/2014
Fremont-Based Ardelyx Inc. Files For $69 Million IPO 5/22/2014
Gene Therapy Biotech Lysogene Reels In $22 Million 5/21/2014
Santa Monica's Kite Pharma, Inc. Gears Up For IPO Debut 5/21/2014
Kymab Locks Down $40 Million For Antibody Research 5/16/2014
Kite Pharma, Inc. Reels In $50 Million Private Financing 4/28/2014
Cancer-Fighter Juno Therapeutics Completes $176 Million Series A Round 4/24/2014
Aerpio Closes $22 Million Financing 4/23/2014
Massachusett's Zafgen Lines Up $86 Million IPO To Bankroll Obesity Drug Push 4/21/2014
San Diego's Vital Therapies, Inc. (VTI) (VTL) Prices $54 Million IPO 4/17/2014
Redwood City Biopharma, Versartis, Inc. (VSAR), Hits High End With $126 Million IPO 3/21/2014
Cambridge's Akebia Therapeutics, Inc. (AKBA) Hauls In $100 Million In Upsized IPO Debut 3/20/2014
Circassia Limited (CIR.L) Raises $332 Million In IPO Debut, Largest Biotech IPO Since 1995 3/14/2014
San Diego Biopharma Lumena Pharmaceuticals Secures $45 Million In Series B Financing Round 3/11/2014
Billionaire-Backed San Diego Startup, Human Longevity Inc., Gets $70 Million To Take On Aging 3/7/2014
NovImmune SA Finishes $66 Million Series B Financing Round 2/18/2014
Flexion Therapeutics (FLXN) Pulls Off $60 Million In IPO Debut 2/12/2014
NephroGenex (NRX) Prices IPO At Low End Of Range, Will Reap About $37.2 Million 2/11/2014
Argos Therapeutics, Inc. (ARGS) Prices Lower Than Expected IPO, Raises $45 Million 2/7/2014
Eleven Biotherapeutics (EBIO) Prices Downsized IPO, Grabs $50 Million 2/6/2014
Already-Rich Startup, Juno Therapeutics, Expands Series A Funding Round To $145 Million 1/15/2014
Alkermes plc (ALKS) Hauls In $250 Million It Doesn't Need, But It May Prevent It From Being Swallowed Up 1/13/2014
Sanofi (France) (SAN.PA) Pays $700 Million For 12 Percent Of Alnylam Pharmaceuticals (ALNY) 1/13/2014
GlycoMimetics, Inc. (GLYC) Finally Prices Upraised IPO At $8 Per Share 1/10/2014
Amgen (AMGN)'s Bay Area Spinoff, Atara Biotherapeutics, Hauls In $52 Million Series B Financing 1/10/2014
Biotech Startup, Juno Therapeutics, Grabs $120 Million To Coax Immune System To Fight Cancer 12/5/2013
Early Stage Biotech VC, 5AM Ventures, Grabs $250 Million 12/5/2013
Zafgen Racks Up $45 Million Series E Round 12/4/2013
NYCEDC's $100 Million Biotech Fund Aims To Form 15 To 20 New Startups By 2020 12/4/2013
Orexigen Therapeutics, Inc. (OREX) Offers $100 Million Of Convertible Senior Notes 12/3/2013
San Diego’s Vital Therapies, Inc. (VTI) Postpones IPO As Biotech Sector Cools Off 11/22/2013
Flagship VentureLabs Takes A Stab At Microbiome Therapy By Launching New Biotech Seres Health 11/21/2013
Evogene Ltd. (EVGN) Hauls In $74 Million In IPO 11/21/2013
Pfizer Inc. (PFE) Sees Something Special In MissionTherapeutics Ltd, Backs Co With $32 Million Series B 11/18/2013
Karyopharm Therapeutics (KPTI) Raises $109 Million in Upsized IPO, Begins Trading Today 11/6/2013
Pronutria Emerges From Stealth With $10.8 Million, Nutrients to Treat Disease 10/22/2013
Cancer Biotech TetraLogic Pharmaceuticals Files for a $104 Million IPO 10/21/2013
Pain Treatment Biotech Egalet Files for a $69 Million IPO 10/17/2013
Startup Seragon Pharmaceuticals Lands $30 Million in Series A Financing 10/16/2013
Vital Therapies, Inc. (VTI) Files For $86.25 Million IPO 10/14/2013
BIND Therapeutics Scrounges Up $70.5 Million in IPO 9/20/2013
With Support From Celgene (CELG) and Other Investors, Acceleron Pharma Raises $93 Million in IPO 9/19/2013
Five Prime Therapeutics, Inc. (FPRX) Stock Soars After $62 Million IPO 9/18/2013
Civitas Therapeutics Raises $38 Million 9/11/2013
Cubist Pharmaceuticals, Inc. (CBST) Prices $700 Million of Convertible Senior Notes 9/5/2013
MicuRx Pharmaceuticals Completes $25 Million Series B Financing 8/22/2013
Regado Biosciences, Inc. (RGDO) Finally Goes Public, Raised $43 Million 8/22/2013
Orphan Disease Biotech Fate Therapeutics Files for a $69 Million IPO 8/14/2013
Startup Drug-Discovery Company BioMotiv Attracts New Millions and a Key Partner 8/13/2013
GlaxoSmithKline (GSK) Plugs Into Bioelectronics With $50 Million Venture Fund 8/8/2013
Agios Pharmaceuticals Prices Initial Public Offering 7/24/2013
Verastem, Inc. (VSTM) Announces Pricing of Public Offering of Common Stock 7/22/2013
OncoMed Pharmaceuticals, Inc. IPO Rakes in $72 Million 7/18/2013
Intrexon Corporation Files $125 Million IPO 7/10/2013
Cardio3 BioSciences's Recent $29 Million Biotech IPO Relied Heavily on Questionable Research 7/9/2013
PTC Therapeutics, Inc. IPO Raises $125 Million Despite Checkered Past 6/20/2013
Iroko Pharmaceuticals Files for a $145 Million IPO 6/19/2013
bluebird bio Prices Upsized IPO Above the Range at $17 6/19/2013
Onconova Therapeutics Inc. Files for $75 Million IPO 6/18/2013
Epizyme (EPZM) Prices IPO at $15 Per Share, Begins Trading Today 5/31/2013
INSYS Therapeutics Completes $37 Million IPO to Back Medical Marijuana Drug 5/21/2013
Karyopharm Therapeutics Raises $48.2 Million in Series B Financing 5/20/2013
Effector Therapeutics Raises $45 Million Series A to Fight Cancer Tumors 5/20/2013
Esperion Therapeutics, Inc. Files for $70 Million IPO 5/16/2013
Quintiles, Inc. (QTRN)'s $947.4M IPO to Spawn a New Billionaire 5/10/2013
Startup Allecra Therapeutics Raises $19.5 Million Series A Financing 4/18/2013
Portola Pharmaceuticals, Inc. Files for $115 Million IPO 4/15/2013
Biotech Chimerix, Inc. Shines in IPO Debut as Interest Grows in Antiviral Drugs 4/12/2013
Cleave Biosciences Adds $10 Million to Series A Financing 4/9/2013
Biotech Receptos Files for a $86 Million IPO 4/5/2013
Enanta Pharmaceuticals, Inc. Raises $56 Million in IPO 3/21/2013
NABsys, Inc. Raises $20 Million From Investors 3/13/2013
Emergence-Backed Veeva Systems, Inc. Seen Seeking $2 Billion Valuation With IPO 3/12/2013
Omthera Pharmaceuticals, Inc. Files for a $75 Million IPO 3/11/2013
Tesaro, Inc. Nets $91 Million 3/7/2013
Ambit Biosciences Refiles for a $58 Million IPO 2/21/2013
Sophiris Bio Inc. (SHS.TO) Files for a $75 Million IPO 2/19/2013
Third Rock Ventures Launches Jounce Therapeutics With $47 Million 2/15/2013
TetraPhase Pharmaceuticals Files for a $86 Million IPO 2/13/2013
e-Therapeutics plc to Raise $62.7 Million 2/11/2013
IPO Could Value Pfizer Inc. (PFE)'s Zoetis at Up to $12.5 Billion 1/21/2013
Onyx Pharmaceuticals, Inc. (ONXX) Announces Pricing of Public Offering of Common Stock 1/16/2013
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of $105,000,000 Principal Amount of Convertible Senior Notes and 13,500,000 Shares of Common Stock 1/16/2013
Aileron Therapeutics Nabs $12 Million for First-Ever Stapled Peptide Clinical Trial 1/14/2013
Foundation Medicine Expands Series B Financing to $56 Million 1/8/2013
Biotech Startup Transcriptic Receives $1.2 Million in Seed Funding Led by Google Ventures 12/14/2012
Pfizer Inc. (PFE) to Launch Animal-Health Unit IPO in Early 2013 12/14/2012
Sofinnova Ventures Raises $312 Million for Life Sciences 12/11/2012
Fluxion Biosciences Secures $20 Million in Series B Financing 12/4/2012
ArmaGen Technologies, Inc. Announces $17 Million Series A Financing 11/30/2012
Intarcia Therapeutics, Inc. Secures $210 Million Financing to Fund Its Global Phase 3 Program 11/15/2012
Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing 11/14/2012
Pearl Therapeutics Grabs $65 Million in VC Funding, Moves COPD Drug Toward Phase III Trials 11/13/2012
Visterra, Inc. Boosts Series A to $26 Million, Adds Bill & Melinda Gates Foundation as Investor 11/9/2012
Abbott Laboratories (ABT) Announces Pricing of AbbVie's $14.7 Billion Private Placement Notes Offering 11/5/2012
Puma Biotechnology Raises $138 Million in Public Offering of Common Stock 10/26/2012
Aclaris Therapeutics Raises $21 Million in Series A Financing 10/24/2012
Intercept Pharmaceuticals, Kythera Biopharmaceuticals Take Off in IPOs 10/12/2012
KaloBios Pharmaceuticals, Inc. Files for IPO 10/5/2012
Massachusetts Institute of Technology (MIT) Economist Pitches $30 Billion Cancer Megafund 10/2/2012
Google Inc. Venture Fund Eyes Biotech Start-Ups With $1 Billion in Pocket 9/24/2012
Startup Heart Drug Developer MyoKardia Lands $38 Million 9/20/2012
Foundation Medicine, Inc. (FMI) Announces $42.5 Million Series B Financing 9/20/2012
Selexys Pharmaceuticals Corporation Completes $23 Million Equity Financing and Signs Agreement With Novartis Pharmaceuticals Corporation (NVS) for Up to $665 Million 9/19/2012
Intercept Pharmaceuticals Files for $75 Million IPO 9/5/2012
Regulus Therapeutics, Inc. Files for Up to $58 Million IPO 8/20/2012
KV Pharmaceutical Files for Chapter 11; Cites Makena Drug Woes 8/6/2012
Burrill & Company Touts New Life Sciences Fund Worth $505 Million 8/3/2012
Biotech Start-Up Atterocor Raises $16 Million Series A 8/3/2012
Idenix Pharmaceuticals, Inc. (IDIX) Prices Public Offering of Common Stock 8/2/2012
Agile Therapeutics, Inc. Raises $40 Million in a Series C Financing 7/19/2012
Durata Therapeutics, Inc. Prices $68 Million IPO 7/19/2012
Juventas Therapeutics, Inc. Raises $22.2 Million Series B Financing 7/16/2012
Synageva BioPharma (GEVA) Announces $80 Million Proposed Public Offering of Common Stock 7/10/2012
GenKyoTex S.A. Raises $26 Million for Phase II Development of Diabetic Nephropathy Drug 7/9/2012
Cytokinetics, Inc. (CYTK) Nabs $60 Million Financing 6/20/2012
Tesaro, Inc. Sets Terms for $81 Million US IPO 6/20/2012
Global Blood Therapeutics, Third Rock Ventures’s First West Coast Startup, Gets $41 Million 6/14/2012
New Firm Select BioVentures Seeks $200 Million for Biotech Deals in Sunshine State 6/13/2012
Rhythm Drums Up $25 Million to Advance Diabetes and Obesity Drugs 6/13/2012
Kleiner Perkins Caufield & Byers Launches New $525 Million Venture Fund 5/18/2012
Arena Pharmaceuticals, Inc. (ARNA) Prices Public Offering of Common Stock 5/17/2012
OncoMed Pharmaceuticals, Inc. Files for $115 Million IPO 5/14/2012
Supernus Pharmaceuticals Announces Closing of Initial Public Offering 5/7/2012
Savient Pharmaceuticals, Inc. (SVNT) Plummets as Hedge Fund Claims It's Bankrupt 5/2/2012
Peter Thiel's Breakout Labs Awards Cash to 6 Ambitious Biotech Startups 4/17/2012
Hyperion Therapeutics Files for $58 Million US IPO 4/13/2012
Supernus Pharmaceuticals Sets Terms for $75 Million US IPO 4/12/2012
BioVentures Closes $268 Million Life Sciences Fund 4/10/2012
Merck Teams With Flagship to Bankroll Biotech Start-ups 4/10/2012
GlaxoSmithKline (GSK), Johnson & Johnson (JNJ) Plot $200 Million Biotech Fund With Index Ventures 3/21/2012
Wellcome Trust to Launch $318 Million Biotech Start-up Fund 3/21/2012
Bellicum Pharmaceuticals, Inc. Closes $20 Million Series B Financing 3/8/2012
Rusnano, US Fund to Invest $760 Million in Pharma Venture 3/6/2012
4s3 Bioscience Lands $20 Million in Venture Funding 3/5/2012
Pfizer Inc. (PFE) Mulls $3 Billion Partial IPO for Animal Healthcare Unit: Report 2/21/2012
ChemoCentryx, Inc. (CCXI) Completes IPO 2/14/2012
Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock 2/13/2012
Celgene (CELG) Pours $15 Million Into Acetylon Pharmaceuticals, Takes "Observer" Role on Board 2/9/2012
Radius Files IPO, Aims for $86 Million 2/7/2012
RaNA Therapeutics, Inc. Emerges With $20.7 Million Startup Financing 1/18/2012
Warp Drive Bio Launches With $125 Million from Third Rock Ventures, Greylock, Sanofi (France) (SAN.PA) 1/10/2012
Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 1/4/2012
Acceleron Pharma Secures $30 Million Private Financing 12/28/2011
Cell Therapeutics, Inc. (CTIC) Announces Institutional Investors Purchase $20 Million of Preferred Stock and Warrants 12/9/2011
Forbion Capital Raises $50 Million to Invest in Health Companies 12/8/2011
arGEN-X Raises $37 Million in Oversubscribed Series B Round 12/1/2011
Fosun Pharma to Float up to $470 Million in Bonds 11/28/2011
Rib-X Pharmaceuticals, Inc. Files for $80 Million IPO 11/28/2011
Portola Pharmaceuticals, Inc. Announces Completion of $89 Million Financing 11/21/2011
Agios Pharmaceuticals Secures $78 Million Series C Financing 11/17/2011
Clovis Oncology (CLVS) Raises $130 Million in IPO 11/16/2011
NewLink Genetics Raises $43.4 Million in IPO 11/11/2011
Human Genome Sciences, Inc. (HGSI) Prices $430 Million Convertible Notes Offering 11/3/2011
Third Rock Ventures Launches SAGE Therapeutics with $35 Million Backing 10/18/2011
Topica Pharmaceuticals Announces Completion of $27 Million Series B Financing 10/18/2011
Foundation Medicine Closes Expanded Series A Financing Totaling $33.5 Million; Third Rock Ventures and Google Inc. Ventures Join as Investors 10/18/2011
Sofinnova Ventures Raises $440 Million for Biotech-Only VC Fund 10/17/2011
Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies 10/12/2011
Kythera Biopharmaceuticals Raises $37.4 Million Financing 9/19/2011
Merck & Co., Inc. (MRK) Creates a $250 Million Venture Capital Fund 9/16/2011
InterMune, Inc. (ITMN) Announces Pricing of Concurrent Public Offerings of 4,000,000 Shares of Common Stock and $135 Million Principal Amount of Convertible Senior Notes 9/14/2011
Valeritas Announces $150 Million Financing 9/13/2011
Orphazyme Raises $19.6 Million in a Series A Financing Round 9/7/2011
VIVUS, Inc. (VVUS) Adds $45.8 Million 8/24/2011
KalVista Pharmaceuticals Launched With $13 Million Series A Funding to Develop Eye Drugs 8/23/2011
Asymchem Laboratories, Inc. Announces $39 Million in VC Funds 8/22/2011
Yaupon Therapeutics Inc. Secures $14.4 Million in Series D Financing 8/11/2011
Enobia Pharma Raises US $40 Million 8/10/2011
SARcode Pulls in $44 Million Series B Financing 7/18/2011
Verastem, Inc. Nabs $32 Million Series B Financing 7/14/2011
DVS Sciences Raises $14.6 Million in Series A Financing to Advance Commercialization of Novel Single-Cell Analysis Technology 7/14/2011
Merrimack Pharmaceuticals Inc. Files $172.5 Million IPO 7/11/2011
Zafgen Secures $33 Million Series C Financing 7/7/2011
Tesaro, Inc. Snags Huge $101 Million Venture Round to Develop Cancer Drugs 6/21/2011
AVEO Oncology (AVEO) Gets $100 Million in Stock Offering 6/16/2011
ReVance Therapeutics, Inc. Announces $45 Million Financing 6/10/2011
Intrexon Corporation Raises $100 Million for Synthetic Biology Initiatives 5/31/2011
Rigel Pharmaceuticals, Inc. (RIGL) Pockets $130 Million in Financing, Seeks To Pick up Pfizer Inc. (PFE)'s Ball and Run With it 5/31/2011
Celldex Therapeutics, Inc. (CLDX) Raises $31.5 Million 5/19/2011
Quintiles, Inc. (QTRN) Seeking $2.23 Billion in Loans for Refinancing 5/11/2011
Naurex Inc. Raises $18 Million to Advance Novel Antidepressant 5/11/2011
Takeda Pharmaceuticals Bets on Fate Therapeutics 5/10/2011
Delenex Therapeutics Extends CHF 30.2 Million Series A Financing Round 5/3/2011
Amgen (AMGN) Outlines Strategy, Growth Objectives and Capital Allocation Plans 4/21/2011
Sagene Pharmaceuticals, Inc. Prices IPO at $16 Per Share, Raises $92 Million in Gross Proceeds 4/20/2011
Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments 4/11/2011
US-China Based Ascletis, Inc. Raises $100 Million from Private Chinese Investors for Specialty Therapeutics Venture 4/6/2011
Tranzyme Pharma Announces Pricing of Its Initial Public Offering, Raises $53.8M 4/4/2011



//-->